SIM
KIN

Spark Investment Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Spark Investment Management’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-45,400
Closed -$154K – 871
2015
Q4 		$154K Buy
+45,400
New +$211K 0.02% 617
2014
Q2 		– Sell
-18,400
Closed -$339K – 775
2014
Q1 		$339K Buy
+18,400
New +$351K 0.05% 423

Other funds holding KIN

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Spark Investment Management's KIN Position: Q1 2016 in Review

Spark Investment Management sold out of Kindred Biosciences, Inc. (KIN) in Q1 2016, closing a stake of 45,400 shares — an estimated $154K sold.

Spark Investment Management first reported a position in KIN in Q1 2014 and held it in 2 quarters. The position peaked at $339K in Q1 2014. 44 funds tracked by Wall St. Rank hold KIN as of Q1 2016.

  • Spark Investment Management reported no remaining Kindred Biosciences, Inc. position as of Q1 2016 after selling out during the quarter.
  • Spark Investment Management sold 45,400 Kindred Biosciences, Inc. shares in Q1 2016, an estimated $154K.
  • Spark Investment Management first reported a position in Kindred Biosciences, Inc. in Q1 2014 and held it in 2 quarters.
  • Spark Investment Management's Kindred Biosciences, Inc. position peaked at $339K in Q1 2014.
  • 44 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2016.

Based on Spark Investment Management's 13F filing for Q1 2016, filed 12 May 2016.